Ding et al verified that CD133 is a liver CSC marker, and reducing CD133 expression in these cells attenuated chemotherapeutic drug 5‐Fu resistance in hepatocellular carcinoma.33 This evidence concerns the gene PROM1 and hepatocellular carcinoma.